Norepinephrine transporter occupancy of venlafaxine in patients with major depressive disorder using positron emission tomography and [18F]FMeNER-D2-Reference-Cited by-同舟云学术

Norepinephrine transporter occupancy of venlafaxine in patients with major depressive disorder using positron emission tomography and [18F]FMeNER-D2

Published:2019 Issue: Volume:29 Page:S322-S323
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Arakawa R.,Stenkrona P.,Takano A.,Svensson J.,Andersson M.,Nag S.,Asami Y.,Halldin C.,Lundberg J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference5 articles.

1. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet,2018

2. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors;Bymaster;Neuropsychopharmacology,2001

3. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study;Takano;Psychopharmacology (Berl),2013

4. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder;Lundberg;Int J Neuropsychopharmacol,2012

5. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2;Arakawa;J Nucl Med,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis;Psychopharmacology;2023-10-19